SIRT1 plays an important role in adipogenesis, but how SIRT1 is regulated in adipogenesis is largely unknown. In this study, we show that both SIRT1 protein and mRNA levels were increased along with CCAAT/enhancer-binding protein α (C/EBPα) during adipocyte differentiation. C/EBPα, but not C/EBPαp30, activated SIRT1 promoter in both HeLa cells and 3T3-L1 preadipocytes. Furthermore, C/EBPα upregulated SIRT1 mRNA and protein levels in HeLa cells and increased SIRT1 expression in a p53-independent manner in Soas2 cells. In preadipocytes, ectopic expression of C/EBPα upregulated SIRT1 protein level and knockdown of C/EBPα led to the decrease of SIRT1 protein level. Moreover, by promoter deletion analysis, gel shift assay and chromatin immunoprecipitation, we found that C/EBPα bound to the SIRT1 promoter at a consensus C/EBPα binding site. These data demonstrate that C/ EBPα regulates SIRT1 expression during adipogenesis by directly binding to the SIRT1 promoter.
Introduction
SIRT1 plays important roles in a wide variety of processes, including stress resistance, energy metabolism and differentiation [1] . In stress resistance, SIRT1 prevents apoptosis by regulating p53, Ku70 and FOXO family proteins [2] [3] [4] [5] . In energy metabolism, SIRT1 regulates glucose homeostasis by regulating PGC-1α transcriptional activity, insulin secretion and insulin sensitivity [6] [7] [8] [9] . In cell differentiation, overexpression of SIRT1 was reported to prevent myogenesis in C2C12 cells by regulating MyoD [10] . SIRT1 also retards adipogenesis in 3T3-L1 cells by inhibiting PPARγ (peroxisome proliferator-activated receptor γ) [11] . In differentiated 3T3-L1 adipocytes, upregulation of SIRT1 is shown to trigger lipolysis and loss of fat [11] . Thus, SIRT1 could be a potential pharmacological target for obesity and obesity-related diseases. It has been reported that resveratrol, a SIRT1 activator, renders the animals resistant to diet-induced obesity and insulin resistance [9, 12, 13] . Because of the important roles of SIRT1 in adipogenesis and lipid metabolism in adipocytes, understanding the mechanisms of regulation of SIRT1 expression during adipocyte differentiation will provide valuable information for therapy of obesity and obesity-related diseases.
Adipocyte differentiation is controlled by a series of cascades of transcription factors. CCAAT/enhancer-binding protein (C/EBP) family proteins are important components of the main cascade [14] . In this cascade, adipogenic inducers first stimulate the expression of C/EBPβ and C/EBPδ, which facilitate the expression of PPARγ, and PPARγ along with C/EBPβ and C/EBPδ activates C/EBPα expression. Then, C/EBPα and PPARγ activate expression of hundreds of genes responsible for terminal adipocyte differentiation. C/EBPα has two main isoforms produced by translation from two in-frame alternative translational initiation sites of the same mRNA, referred to as C/EBPαp42 and C/EBPαp30 [15] . C/EBPαp30 is without the N-terminal 12 kDa of C/EBPαp42, lacks the transcriptional activity of C/EBPαp42 and sometimes acts as a dominant-negative form of C/EBPαp42 [16, 17] . Usually, the full-length C/EBPαp42 is mentioned as C/EBPα, which plays essential roles in adipocyte differentiation [18] [19] [20] .
During adipogenesis, SIRT1 expression is increased [11] . But the underlying regulatory mechanism is still unclear. Foxo3a and p53 are responsible for SIRT1 increase during nutrient starvation [3] , and SIRT1 increase induced by DNA damage drugs is controlled by E2F1 [21] . In this study, we found that C/EBPα regulates SIRT1 expression during adipogenesis.
Results

SIRT1 increases along with C/EBPα in the process of 3T3-L1 cell differentiation
The protein level of SIRT1 was reported to increase during adipogenesis of 3T3-L1 cells [22] . Similarly, we observed that the protein level of SIRT1 was elevated in the process of adipogenesis accompanied with the increase of C/EBPα protein level ( Figure 1A) . At the same time, the mRNA level of SIRT1 was also gradually elevated on days 2 and 4 ( Figure 1B and 1C) . This result suggests that the increase of SIRT1 protein level could be due to the increase of SIRT1 mRNA level. In undifferentiated 3T3-L1 preadipocytes, SIRT1 was almost equally immunostained in different cells ( Figure 1D , upper panel). The protein level of SIRT1 was dramatically upregulated in differentiated 3T3-L1 cells, which were marked with the positive immunostaining of C/EBPα as well as the appearance of lipid droplets ( Figure 1D, lower panel) . The immunostaining of SIRT1 in undifferentiated cells was very weak ( Figure 1D ). These data demonstrate that SIRT1 expression only significantly increased in adipogenic cells, and exclude the possibility that the increase of SIRT1 level is induced by adipogenic inducers in undifferentiated cells. Taken together, these results suggest that SIRT1 expression might be upregulated by C/EBPα in adipogenic cells, likely at the transcriptional level.
C/EBPα activates SIRT1 promoter
To identify the possible transcription factors responsible for SIRT1 upregulation during adipogenesis, a reporter construct containing a 2852 bp region of the SIRT1 promoter was applied to detect the SIRT1 promoter activity. The C/EBP family transcription factors, including C/EBPβ, C/EBPαp30, C/EBPα and CHOP-10, were reported to increase during adipogenesis [23] and thus were examined in our luciferase assay. As shown in Figure 2A , the SIRT1 promoter was activated by C/EBPα by about 9-fold in HeLa cells, but not by C/EBPβ, C/ EBPαp30 or CHOP-10. The expression of these C/EBP family proteins was confirmed by western blot ( Figure  2B ). Moreover, the SIRT1 promoter was dose-dependently activated by C/EBPα, and was not activated by C/ EBPαp30 ( Figure 2C ). In addition, C/EBPα dramatically activated the SIRT1 promoter in 3T3-L1 preadipocytes ( Figure 2D ). These data suggest that C/EBPα is involved in regulating SIRT1 transcription.
C/EBPα upregulates endogenous SIRT1 expression independently of p53
To further investigate the effect of C/EBPα on SIRT1 transcription, C/EBPα was overexpressed in HeLa cells, and C/EBPαp30 was used as the negative control. As shown in Figure 3A , SIRT1 mRNA level was elevated in the cells transfected with C/EBPα, but not in the cells transfected with C/EBPαp30. Overexpression of C/EBPα upregulated the SIRT1 mRNA level by about 2-fold when compared with the cells transfected with the control vector ( Figure 3B) . Similarly, the effect of C/EBPα on the protein level of SIRT1 was examined by immunostaining in HeLa cells. As shown in Figure 3C , no significant 
The relative SIRT1 mRNA level change of the SIRT1 immunofluorescence was observed when the cells were transfected with empty vector or C/ EBPαp30. By contrast, the SIRT1 protein level in the cells expressing exogenous C/EBPα was significantly increased compared with that in the cells without exogenous C/EBPα expression in the same field ( Figure 3C , lower panel). The effect of C/EBPα on the protein level of SIRT1 was also confirmed by western blot. As shown in Figure 3D , overexpression of C/EBPα, but not of C/ EBPαp30, significantly increased the SIRT1 protein level. These results demonstrate that C/EBPα is capable of inducing endogenous SIRT1 mRNA transcription and its protein expression.
It was reported that acute nutrient withdrawal activated Foxo3a to induce p53-mediated SIRT1 expression [24] . To examine whether p53 is involved in C/EBPα-dependent SIRT1 expression, we tested the effect of C/ EBPα on SIRT1 expression in Soas-2 cells lacking the functional p53. Consistent with the result of Figure 3C , the SIRT1 protein level in the Soas-2 cells expressing exogenous C/EBPα was significantly increased compared with that in the cells without exogenous C/EBPα expression in the same field ( Figure 3E ). These results were further confirmed by western blot, and the expression of C/EBPα and C/EBPαp30 was validated using anti-C/ EBPα antibody ( Figure 3F ). These results show that C/ EBPα is capable of upregulating SIRT1 expression in a p53-independent manner.
C/EBPα regulates SIRT1 expression in preadipocytes
To further confirm the effect of C/EBPα on SIRT1 expression in preadipocytes, the plasmids encoding C/ EBPα, C/EBPαp30, C/EBPβ or CHOP-10 were transfected into 3T3-L1 preadipocytes. As shown in Figure  4A , overexpression of C/EBPα, but not C/EBPαp30, C/ EBPβ or CHOP-10, resulted in the increase of SIRT1 protein level. Although C/EBPα was very difficult to be detected in 3T3-L1 preadipocytes (data not shown), C/ EBPα was expressed and detectable in primary cultured rat preadipocytes ( Figure 4B ) as described previously [25] . To further investigate whether C/EBPα is important for regulation of SIRT1 expression, lentivirus expressing C/EBPα RNAi was used to infect primary cultured rat preadipocytes. 3 days after infection, SIRT1 expression declined accompanied with the decrease of C/EBPα, when analyzed by western blot ( Figure 4C ). These results demonstrate that C/EBPα plays an important role in regulation of SIRT1 expression in preadipocytes.
C/EBPα directly binds to SIRT1 promoter and upregulates SIRT1 transcription
To identify the underlying mechanism by which C/ EBPα upregulates SIRT1 transcription, a series of SIRT1 promoter fragments were used to examine the effect of C/EBPα on SIRT1 promoter activity. As shown in Figure  5A , successive deletions of SIRT1 promoter revealed that C/EBPα greatly activated the SIRT1 promoter fragment predicted using the Match algorithm (http://www.generegulation.com/cgi-bin/pub/programs/match). These two sites were named as C/EBPα binding site 1 (CBS1) and 2 (CBS2), respectively ( Figure 5B ).
To test whether C/EBPα could bind to CBS1 or CBS2, CBS1 and CBS2 were synthesized and labeled to perform electrophoretic mobility shift assay (EMSA). As shown in Figure 5C , two possible C/EBPα binding bands appeared and were indicated with a solid or open arrow. Both of the bands could be competed off by respective cold probes. The band indicated with the solid arrow only appeared when the samples transfected with C/EBPα were applied to CBS1 probe binding. Almost equal expression of C/EBPα and C/EBPαp30 in nuclear extracts was confirmed by western blot (data not shown). To further identify the specific C/EBPα binding bands, a consensus CBS probe with the same length of CBS1 or CBS2 probe was applied as a positive control. As shown in Figure 5D left panel, in the two possible binding bands, only the band indicated with the solid arrow appeared. Although the molecular weight was different between C/EBPα and C/EBPαp30, the shift distance in EMSA assay was not significantly different [15] . Thus, it was unlikely that the band indicated by the open arrow was due to C/EBPαp30 binding. Furthermore, as C/ EBPα was tagged with myc, anti-myc and anti-C/EBPα antibodies were used in the supershift assay. As shown in Figure 5D middle and right panels, only the band indicated by the solid arrow disappeared when the indicated antibodies were added in the reaction. Therefore, the band indicated with the solid arrow was the specific band, and all other bands are nonspecific bands. Together with the results in Figure 5C , these data suggest that the CBS1 site is the C/EBPα binding element in SIRT1 promoter, and C/EBPαp30 does not bind to CBS1. This is consistent with our results that C/EBPαp30 does not regulate SIRT1 expression. To test the in vivo binding of C/ EBPα to the CBS1 site, we performed chromatin immunoprecipitation (ChIP) assay with anti-C/EBPα antibody. As shown in Figure 5E , the SIRT1 promoter fragment containing the CBS1 site was coprecipitated with endogenous C/EBPα in differentiated 3T3-L1 adipocytes. Taken together, C/EBPα was demonstrated to bind to the CBS1 site of SIRT1 promoter both in vitro and in vivo.
To examine whether the CBS1 site is important for SIRT1 promoter activation, CBS1 and CBS2 were mutated in the 629 bp SIRT1 promoter and tested in the promoter activity assay ( Figure 5F ). Only mutation of the CBS1 site significantly inhibited the activation of SIRT1 promoter by C/EBPα ( Figure 5G ). This is consistent with the results from the EMSA assay that C/EBPα only binds to the CBS1 site. SIRT1 has been reported to be upregulated in mouse white adipose tissue under fasting condition [8] . To test whether the increase of SIRT1 transcription in mouse white adipose tissue under fasting condition is associated with binding of C/EBPα to the CBS1 site of SIRT1 promoter, we performed ChIP assay with anti-C/EBPα antibody using white adipose tissue from mice fed ad libitum, fasted for 24 h or refed for 2 h after 24 h of fasting. As expected, binding of C/EBPα to the CBS1 region of SIRT1 promoter was enhanced by fasting, and then attenuated by re-feeding ( Figure 5H ).
All these results illustrate that C/EBPα directly binds to the CBS1 site of SIRT1 promoter to upregulate SIRT1 transcription.
Discussion
It has been reported that SIRT1 transcription is regulated by p53 and Foxo3a under fasting conditions [24] or regulated by E2F1 in response to DNA damage [21] . Here, we demonstrate that SIRT1 expression is regulated by C/EBPα during adipogenesis. We observed that SIRT1 protein level increased along with C/EBPα during adipocyte differentiation (Figure 1) , which is consistent with the previous report [22] . Overexpression of C/EBPα was sufficient to increase SIRT1 expression in different cells, whereas knockdown of C/EBPα by RNAi in rat preadipocytes led to decrease of SIRT1 protein level (Figures 3  and 4) . Furthermore, we identified a C/EBPα binding site in the SIRT1 promoter ( Figure 5) . However, the SIRT1 promoter containing the 372 or 202 bp fragment without the identified binding site was still activated by C/EBPα. These data indicate that there should be other C/EBPα binding sites in the SIRT1 promoter. In addition, we found that SIRT1 level increased along with C/EBPα in white adipose tissue from mice fasted overnight (data not shown) and the binding of C/EBPα to SIRT1 promoter was enhanced by fasting ( Figure 5H) , suggesting that C/EBPα might regulate SIRT1 transcription in adipose tissue in vivo. All these results show that C/EBPα is an important regulator of SIRT1 transcription, in addition to p53, Foxo3a and E2F1 [21, 24] .
During the process of adipocyte differentiation, C/ EBPα and PPARγ are master adipogenic factors [26] . Overexpression of SIRT1 repressed PPARγ and C/EBPα, and as a result inhibited adipogenesis in 3T3-L1 cells [11] . In this study, we found that C/EBPα stimulated the transcription of SIRT1. Similarly, C/EBPα also stimulates the expression of β3-adrenergic receptor, which can stimulate lipolysis [27] . In addition, we found that the binding of C/EBPα to SIRT1 promoter was enhanced after fasting ( Figure 5 ), which is consistent with previous studies
showing that SIRT1 repressed PPARγ after starvation to promote fat mobilization [11, 28] . Therefore, it is likely that C/EBPα might stimulate adipogenesis and also induce other genes to gradually suppress adipogenesis, thus to control adipocyte differentiation at an appropriate degree to maintain the adipose homeostasis in vivo. In addition to acting as a master adipogenic transcription factor, C/EBPα is required to confer insulin sensitivity to the adipocyte [29] . SIRT1 plays an important role in insulin sensitivity [9] . PPARγ agonists have been already applied in clinic to promote insulin sensitivity [30] . All these findings implicate that SIRT1, C/EBPα and PPARγ might coordinate to regulate adipogenesis as well as insulin sensitivity in adipocytes. Future studies focused on how adipogenesis is naturally terminated to control the lipid accumulation in adipocytes should provide new approaches for preventing or treating obesity.
Materials and Methods
Plasmids pcDNA-C/EBPα and pcDNA-C/EBPαp30 expressing two isoforms of C/EBPα, C/EBPα and C/EBPαp30, respectively; and pcDNA-C/EBPβ expressing C/EBPβ were all kindly provided by G Hu [31] . pCS2+-SIRT1 expressing SIRT1 was constructed by insertion of SIRT1 cDNA fragment cut from pBabepuro-SIRT1 [4] into pCS2+ at the BamHI site. pcDNA-CHOP-10 expressing human CHOP-10 was constructed by insertion of CHOP-10 cDNA fragment into pCDNA3.1/myc-His(−) B (Invitrogen) at EcoRI and BamHI sites. CHOP-10 cDNA fragment was amplified by RT-PCR using RNA extracted from HeLa cells with 5′-CGG AAT TCA TGA GCG GGT GGC AGC GA-3′ and 5′-GCG GAT CCC TTG GTG CAG ATT CAC CAT TCG-3′ as primers. pTA-202bp, pTA-372bp, pTA-629bp, pTA-1487bp and pTA-2852bp SIRT1 promoters containing various SIRT1 promoter fragments, which began at position −202, −372, −629, −1487 or −2852 relative to the translation start site, were kindly provided by T Finkel [24] . pGL3-629bp SIRT1 promoter containing 629 bp SIRT1 promoter was constructed by insertion of the 629 bp SIRT1 promoter fragment to pGL3-basic (Promega) at KpnI and XhoI sites. The 629 bp SIRT1 promoter fragment was amplified by PCR from pTA-629bp SIRT1 promoter using 5′-GGG GTA CCG ATC TTT CCA GGA GGG CAA C-3′ and 5′-CCG CTC GAG CTT CCA ACT GCC TCT CTG GC-3′ as primers.
Cell culture, transfection and induction of 3T3-L1 adipogenesis
HeLa, Soas-2, HEK293T and 3T3-L1 preadipocytes cells were grown in DMEM with 10% newborn calf serum. The preadipocytes were prepared from epididymal, subcutaneous and mesenteric adipose tissue from about 7-week-old male SD rats according to a method previously described [32] , and cultured in DMEM + F12 (1:1) with 10% FBS. Rats were obtained from Slaccas (Shanghai, China), and used in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences. Transfection was performed with lipofectamine 2000 according to the manufacturer's instruction. To differentiate 3T3-L1 cells, after growing them to confluence, the cells were allowed to grow for 2 days, and then exposed to fresh differentiation medium containing DMEM, 10% FBS, 1 µM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, 10 µM troglitazone and 1 µg/ml insulin. After 2 days, the cells were refed with fresh DMEM containing 10% FBS, 10 mM troglitazone and 1 µg/ml of insulin for another 2 days. Then, the cells were cultured in DMEM with 10% FBS.
Western blot
Western blot was carried out as previously described [33] , using rabbit anti-C/EBPα antibody (1:500), mouse anti-Myc antibody (1:1 000) from Santa Cruz Biotechnology; rabbit anti-SIRT1 antibody (1:10 000) from Upstate, mouse anti-tubulin antibody (1:10 000) from Sigma, mouse anti-CHOP-10 antibody (1:500) from Abcam and secondary antibodies conjugated to horseradish peroxidase (1:1 000) from Jackson ImmunoResearch. The bound immune complexes were detected with SuperSignal west pico chemiluminescent substrate (Pierce).
RNA extraction and RT-PCR
RNA was extracted with Trizol and reverse transcribed to cDNA. SIRT1 and β-actin were detected by PCR using 5′-CCT GAC TTC AGA TCA AGA GAC GGT A-3′ and 5′-CTG ATT AAA AAT GTC TCC ACG AAC AG-3′ as primers for mouse SIRT1; 5′-TGC CGC ATC CTC TTC CTC-3′ and 5′-GTC GCC TTC ACC GTT CCA-3′ for mouse β-actin; 5′-GCA ACA TCT TAT GAT TGG CAC AG-3′ and 5′-TTT GGA TTC CCG CAA CCT G-3′ for human SIRT1; and 5′-TGC TGT CCC TCT ACG CCT CTG-3′ and 5′-GCC GCA AGA TTC CAT ACC C-3′ for human β-actin. Real-time PCR was performed using 5′-GCC AGA GTC CAA GTT TAG AAG A-3′ and 5′-CCA TCA GTC CCA AAT CCA G-3′ as primers for human SIRT1; 5′-TGA CGT GGA CAT CCG CAA AG-3′ and 5′-CTG GAA GGT GGA CAG CGA GG-3′ for human actin as internal control; 5′-CAC ATG CCA GAG TCC AAG TT-3′ and 5′-AAA TCC AGA TCC TCC AGC AC-3′ for mouse SIRT1; and 5′-CAC TGG TCT AGG ACC CGA GAA-3′ and 5′-AGG GGG AGA TGT TCA GCA TGT-3′ for mouse 36b4 as internal control.
Immunofluorescence
Immunofluorescence was performed as previously described [34] . Differentiated 3T3-L1 cells were stained by rabbit anti-C/ EBPα antibody (1:500) and mouse anti-SIRT1 antibody (Sigma, 1:1 000), rat preadipocytes were stained by rabbit anti-C/EBPα antibody (1:500) and other cells were stained by mouse anti-Myc antibody (1:1 000) and rabbit anti-SIRT1 antibody (1:10 000). After incubation with Cy3 conjugated anti-rabbit IgG (Jackson ImmunoResearch) and/or Alexa fluor 488 conjugated anti-mouse IgG (Invitrogen, 1:1 000), the cells were stained with Hoechst 33258 (0.25 µg/ml). Images were acquired at room temperature on a microscope (Olympus IX71).
Luciferase assay
After transfection for 24 h, HeLa cells in 24-well plates were harvested for luciferase assay. A β-galactosidase-expressing plasmid from Promega was included in each transfection to monitor the transfection efficiency. The transfected plasmids were bal- anced with empty vector. Luciferase activities were determined by luciferase assay kit from Promega. Luciferase activity was normalized to β-galactosidase activity, which was determined as described previously [35] .
Electrophoretic mobility shift assay
EMSA was performed with a dig gel shift kit (Roche) according to the manufacturer's instruction. The nuclear extracts were prepared from HeLa cells transfected with empty vector, C/EBPα or C/EBPαp30, according to the method described previously [36] . The CBS1 and CBS2 probes, corresponding to the predicted C/ EBP binding sites (CBS) at −567 to −550 and −426 to −409, relative to the translation start site, are 5′-AGG GAG ATT GGG AGA GAG CG-3′ and 5′-GCC CCT GAG GTA AAA GCC GA-3′, respectively. Consensus C/EBPα binding sequence probe is 5′-TGC AGA TTG CGC AAT CTG CA-3′. Mouse anti-myc antibody and rabbit anti-C/EBPα antibody were used for supershift assay.
Preparation of recombinant lentivirus pLentiLox 3.7-H1 with the H1 promoter and pLentiLox 3.7-H1 containing Renilla luciferase RNAi were obtained as described previously [9] . To construct a plasmid expressing C/EBPα RNAi, 5′-GAT CCG AAG TCG GTG GAC AAG AAC TTC AAG AGA GTT CTT GTC CAC CGA CTT CTT TTT TGG AAG-3′ and 5′-TCG ACT TCC AAA AAA GAA GTC GGT GGA CAA GAA CTC TCT TGA AGT TCT TGT CCA CCG ACT TCG-3′ were annealed and cloned into pLentiLox 3.7-H1 at BamH1 and XhoI sites. The recombinant lentivirus were packaged and harvested as described previously [9] . Rat preadipocytes were infected with lentivirus in the presence of 8 µg/ml polybrene for 12 h each time and totally three times.
Chromatin immunoprecipitation assay
ChIP assay for cultured cells was performed using a ChIP assay kit from Upstate. Chromatin was immunoprecipitated with anti-C/ EBPα antibody (1:200). The coprecipitated chromatin was analyzed by PCR using 5′-TTT CCA GGA GGG CAA CAG GC-3′ and 5′-GCC TTG CCC TTG CTC TGT G-3′ as primers. The PCR product is a fragment of SIRT1 promoter spanning from −625 to −483. The ChIP assay with white adipose tissues was performed as described previously with modifications [37] . The tissues were minced and fixed for 4 h in PBS containing 1% formaldehyde and 1 mM PMSF, 1 µg/ml Aprotinin and 1 µg/ml Pepstatin A. Subsequently, the samples were rinsed twice with PBS and homogenized in 1 ml of ice-cold cell lysis buffer (10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 3 mM MgCl 2 , 0.5% NP-40 and supplemented with the above protease inhibitors) and then incubated at 4 °C for 5 min. Then, the samples were centrifuged at 15 000 × g for 10 min, and both the supernatant and the fat were discarded. The pellet was resuspended in 1% SDS, 5 mM EDTA, 50 mM Tris-HCl (pH 8.1) supplemented with protease inhibitors, and sonicated using a Sonic dismembrator with a microtip probe set to power an output of 5-6 W for 10 cycles of 30 s on and 40 s off for each cycle. Then, the samples were used for ChIP assay as cultured cells.
Animals
All animals were maintained and used in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences. Male C57BL/6 mice at 9 weeks of age were purchased from Slaccas (Shanghai, China). Nine mice were randomly divided into three groups and fed chow (D12450B, Research diets). After 1 week, the mice were fed as usual, fasted for 24 h, or refed 2 h after 24 h of fasting. The animals were sacrificed, and the white adipose tissues were removed and snap-frozen for ChIP assay.
Statistical analysis
Data are expressed as mean ± SD of at least three independent experiments. Statistical significance was assessed by Student's t-test except indicated. Differences were considered statistically significant at P < 0.05.
